Neos Therapeutics Inc (NEOS) Return on Investment ROI from the third quarter of 2020 to third quarter of 2019 and for the year 2020, average high and low, overall ranking from Sep 30 2020 to Sep 30 2019 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Neos Therapeutics Inc   (NASDAQ: NEOS)


Neos Therapeutics Inc's ROI from its third quarter of 2020 to the third quarter of 2019 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Neos Therapeutics Inc's ROI in the third quarter of 2020?
Neos Therapeutics Inc recorded a cumulative net loss of $-22 million during 12 months ending in the third quarter of 2020, resulting in a negative return on investment (ROI) of -195.49%.

Within the Healthcare sector 680 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2020 from 0 to 4142.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Investment Change TTM -72.99 % -47.9 % -26.37 % -15.28 % -5.7 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -5 2 21 28 31
Return On Investment (TTM) - -94.21 % -62.25 % -49.48 % -54.96 %
NEOS's Overall Ranking # 4142 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -44.55 % -27.25 % -18.86 % -17.49 % 6.98 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -22 -19 -17 -17 -23

NEOS Company Profile >> Back to NEOS Roi Comparisons >> See Annual NEOS Return On Investment



Return On Investment NEOS's Ranking
Within: No.
Industry # 330
Sector # 681
Overall # 4142

Return On Investment Statistics
High Average Low
-10.57 %
-81.2 %
-129.96 %
(Mar 31 2016)   (Dec 31 2018)







Financial Statements
Neos Therapeutics Inc's III. Quarter Investments $ -5 Millions NEOS's Balance sheet
Neos Therapeutics Inc's III. Quarter Income $ -5 Millions Quarterly NEOS's Income Statement
NEOS's Income by Division See NEOS's Income by Division


NEOS Annual Return On Investment (Dec 31 2019)
2019		 (Dec 31 2018)
2018		 (Dec 31 2017)
2017		 (Dec 31 2016)
2016		 (Dec 31 2015)
2015
Total Investments in Millions 28 54 70 58 106
Y / Y Investment Growth -49.28 % -22.22 % 19.32 % -44.86 % -
Net Income in Millions -17 -52 -66 -83 -31
Y / Y Net Income Growth - - - - -
Annual Return On Investment -61.42 % -95.25 % -94.98 % -142.55 % -29.03 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NEOS's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NEOS's Competitors
Subscribers only: Roi for Neos Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for NEOS's Customers

Other Ratios
NEOS's Roa NEOS's Inventory Turnover Ratio NEOS's Growth Rates NEOS's Dividend Statistics
NEOS's Profitability Ratios NEOS's Asset Turnover Ratio NEOS's Dividend Growth
NEOS's Roe NEOS's Valuation Ratios NEOS's Financial Strength Ratios NEOS's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2020, within Healthcare Sector ROI

Date modified: 2026-09-08T15:10:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.